Valneva SE (INRLF)
2.49
0.00 (0.00%)
USD |
OTCM |
Oct 30, 16:00
Valneva Enterprise Value : 573.64M for Oct. 30, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 573.64M |
| October 29, 2026 | 573.64M |
| October 28, 2026 | 573.64M |
| October 27, 2026 | 573.64M |
| October 26, 2026 | 740.53M |
| October 23, 2026 | 740.53M |
| October 22, 2026 | 740.53M |
| October 21, 2026 | 740.53M |
| October 20, 2026 | 740.53M |
| October 19, 2026 | 740.53M |
| October 16, 2026 | 740.53M |
| October 15, 2026 | 740.53M |
| October 14, 2026 | 740.53M |
| October 13, 2026 | 740.53M |
| October 12, 2026 | 740.53M |
| October 09, 2026 | 740.53M |
| October 08, 2026 | 740.53M |
| October 07, 2026 | 740.53M |
| October 06, 2026 | 740.53M |
| October 05, 2026 | 740.53M |
| October 02, 2026 | 740.53M |
| October 01, 2026 | 740.53M |
| September 30, 2026 | 740.53M |
| September 29, 2026 | 740.53M |
| September 28, 2026 | 740.53M |
| Date | Value |
|---|---|
| September 25, 2026 | 740.53M |
| September 24, 2026 | 740.53M |
| September 23, 2026 | 740.53M |
| September 22, 2026 | 670.36M |
| September 21, 2026 | 670.36M |
| September 18, 2026 | 670.36M |
| September 17, 2026 | 700.72M |
| September 16, 2026 | 714.92M |
| September 15, 2026 | 714.92M |
| September 14, 2026 | 714.92M |
| September 11, 2026 | 714.92M |
| September 10, 2026 | 725.35M |
| September 09, 2026 | 725.35M |
| September 08, 2026 | 725.35M |
| September 04, 2026 | 725.35M |
| September 03, 2026 | 725.35M |
| September 02, 2026 | 725.35M |
| September 01, 2026 | 725.35M |
| August 31, 2026 | 725.35M |
| August 28, 2026 | 725.35M |
| August 27, 2026 | 725.35M |
| August 26, 2026 | 725.35M |
| August 25, 2026 | 725.35M |
| August 24, 2026 | 725.35M |
| August 21, 2026 | 725.35M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Nicox SA | -75.50M |
| DBV Technologies SA | 452.86M |
| Cellectis SA | 46.19M |
| Genfit SA | -- |
| Innate Pharma SA | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -36.28M |
| Revenue (Quarterly) | 40.62M |
| Total Expenses (Quarterly) | 76.90M |
| EPS Diluted (Quarterly) | -0.1913 |
| Gross Profit Margin (Quarterly) | 4.58% |
| Profit Margin (Quarterly) | -89.31% |
| Earnings Yield | -42.04% |
| Normalized Earnings Yield | -42.04 |